Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database-Reference-Cited by-同舟云学术

Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: a retrospective analysis of the Surveillance, Epidemiology and End Results database

Published:2015-09-30 Issue:6 Volume:6 Page:308-312
ISSN:2040-6207
Container-title:Therapeutic Advances in Hematology
language:en
Short-container-title:Therapeutic Advances in Hematology

Author:

Giri Smith¹,Pathak Ranjan²,Martin Mike G.¹,Bhatt Vijaya Raj³

Affiliation:

1. Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA

2. Department of Medicine, Reading Health System, Reading, PA, USA

3. University of Nebraska Medical Center, Department of Internal Medicine, Division of Hematology-Oncology, 987680 Nebraska Medical Center, Omaha, NE 68198-7680, USA

Publisher

SAGE Publications

Subject

Hematology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2040620715607416

Reference14 articles.

1. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma

2. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

3. Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta

4. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic Syndrome: Clinical Characteristics and Significance of Preclinically Detecting Biallelic Mutations in the TET2 Gene;Life;2024-05-16

2. Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine;Frontiers in Oncology;2024-02-07

3. Characteristics, primary treatment, and survival of MDS/MPN with neutrophilia: a population-based study;Blood Advances;2023-12-15

4. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach;Cell Communication and Signaling;2023-11-29

5. Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review;Cancers;2023-06-13